Cracking The Code: Understanding Analyst Reviews For ACADIA Pharmaceuticals
Cracking The Code: Understanding Analyst Reviews For ACADIA Pharmaceuticals
破解密碼：了解分析師對阿卡迪亞製藥的評論
26 analysts have expressed a variety of opinions on ACADIA Pharmaceuticals (NASDAQ:ACAD) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的一個季度中，26位分析師對阿卡迪亞製藥公司（納斯達克股票代碼：ACAD）表達了各種觀點，從看漲到看跌，提出了各種各樣的觀點。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表簡要概述了他們最近的評級，重點介紹了過去30天中情緒的變化，並將其與前幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $33.2, a high estimate of $42.00, and a low estimate of $19.00. This current average represents a 9.34% decrease from the previous average price target of $36.62.
分析師評估的12個月目標股價揭示了進一步的見解，平均目標價爲33.2美元，最高估計爲42.00美元，低估值爲19.00美元。目前的平均價格比之前的36.62美元的平均目標股價下降了9.34％。
Decoding Analyst Ratings: A Detailed Look
解碼分析師評級：詳細介紹
The perception of ACADIA Pharmaceuticals...
通過分析師...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。